Chen T, Huang Q, Chen X, Zhu J, Kong D, Liao X, Li. Trimeric hemagglutinin vaccine provides chickens complete protection against lethal H5 subtype avian influenza virus from clade 2.3.4.4b. Emerg Microbes Infect. 2026 Dec;15(1):2678649
H5 subtype highly pathogenic avian influenza virus (HPAIV) of clade 2.3.4.4b has prevailed globally, causing economic losses in the poultry industry and posing zoonotic threats. While inactivated vaccines are advantageous tools for prevention and control, their reliance on egg-based production and live viruses necessitates safer alternatives. Based on multiple design strategies, including signal peptide replacement, transmembrane domain truncation, fusion with Trimer-tag or Helicobacter pylori Ferritin, and adaptation of the EABR [ESCRT (endosomal sorting complex required for transport)- and ALIX (ALG-2-interacting protein X)-binding region] technology, three trimeric hemagglutinin (HA) antigens (S836-Trimer, S836-Ferritin, and S836-ESCRT) were constructed, transiently expressed in HEK293 cells, and the immunogenicity of the candidate antigens was subsequently evaluated through animal studies. Among these, S836-Trimer was identified as optimal based on secretory expression, conformational stability, and immunogenicity. Animal experiments showed that a single immunization with 10 μg of S836-Trimer provided complete protection against a lethal challenge with an epidemic clade 2.3.4.4b virulent strain in chickens, comparable to that of an existing commercial trivalent inactivated vaccine. Subsequently, CHO cell lines stably expressing S836-Trimer were established, achieving ~10-fold higher antigen yield than HEK293 cells and demonstrating the feasibility of large-scale production of the candidate vaccine. Animal trials confirmed the single-dose efficacy of this CHO cell-derived vaccine. Overall, our research indicates that developing candidate avian influenza vaccines based on mammalian cell expression systems is a promising strategy.
See Also:
Latest articles in those days:
- Weekly US Influenza Surveillance Report: Key Updates for Week 45, ending November 14, 2026 11 hours ago
- Anatomical Compartmentalization in Chickens Drives Divergent H9N2 Influenza Evolution Toward Human Receptor Binding and Immune Escape 1 days ago
- Epidemiologic Variability and Clinical Severity Across 11 Influenza Seasons in Children 2 days ago
- Molecular Epidemiology of Clade 2.3.4.4b H5N1 High-Pathogenicity Avian Influenza in South Africa, 2025-2026 2 days ago
- Structural basis of avian-to-human receptor-binding adaptation in H9Ny influenza A virus hemagglutinin 2 days ago
[Go Top] [Close Window]


